Imaging is paramount for the early detection and clinical staging of breast cancer, as well as
to inform management decisions and direct therapy. PET–MRI is a quantitative hybrid …

In this analysis, the role of metabolic imaging with fluorine 18 fluorodeoxyglucose (FDG) in
breast cancer is reviewed. The analysis was limited to recent works by using state-of-the-art …

The therapeutic options for patients with noninvasive or invasive breast cancer are complex
and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include …

Breast cancer is the most common malignancy in women in the United States and is second
only to lung cancer as a cause of cancer death. The overall management of breast cancer …

Purpose The aim of this study was to determine the impact of the main clinicopathological
and biological prognostic factors of breast cancer on 18 F-fluorodeoxyglucose (FDG) uptake …

Purpose We compared the ability of 68Ga-FAPI PET//CT with 18FDG PET/CT imaging
techniques to detect additional lesions in breast cancer patients that may affect further …

Breast cancer is the most common malignancy in women in the United States and is second
only to lung cancer as a cause of cancer death. The overall management of breast cancer …

Aim We aimed to compare the roles of 68 Ga-FAPI-04 PET/CT and 18 F-FDG PET/CT in the
evaluation of primary tumor and metastases in primary and recurrent breast cancer …

OBJECTIVE. FDG PET/CT affects the management of patients with breast cancer in multiple
settings, including initial staging, treatment response assessment, and evaluation of …

Radiomics has been spotlighted as imaging biomarker for estimation of intratumoral
heterogeneity (ITH) which is regarded as the main reason for resistance to tumor treatment …